Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Luca Mologni. (2012) Inhibitors of the anaplastic lymphoma kinase. Expert Opinion on Investigational Drugs 21:7, pages 985-994.
Read now
Read now
Articles from other publishers (4)
Detina Zalli, Zhongyi Mai, Eriona Ferati, Aurela Ramaj, Renilda Bregu & Md Zahidul I. Pranjol. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
31
.
Jian-Hua Luo, Silvia Liu, Junyan Tao, Bao-Guo Ren, Katherine Luo, Zhang-Hui Chen, Michael Nalesnik, Kathleen Cieply, Tianzhou Ma, Shi-Yuan Cheng, Qi Chen, George K. Michalopoulos, Joel B. Nelson, Rohit Bhargava, Jun Zhang, Deqin Ma, David Jarrard, Arjun Pennathur, James D. Luketich, Donald B. DeFranco, Satdarshan Paul Monga, George Tseng & Yan-Ping Yu. (2020) Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings. Oncogene 40:6, pages 1064-1076.
Crossref
Crossref
Yan-Ping Yu, Peng Liu, Joel Nelson, Ronald L. Hamilton, Rohit Bhargava, George Michalopoulos, Qi Chen, Jun Zhang, Deqin Ma, Arjun Pennathur, James Luketich, Michael Nalesnik, George Tseng & Jian-Hua Luo. (2019) Identification of recurrent fusion genes across multiple cancer types. Scientific Reports 9:1.
Crossref
Crossref
Sayyed K. Zaidi, Daniel W. Young, Amjad Javed, Jitesh Pratap, Martin Montecino, Andre van Wijnen, Jane B. Lian, Janet L. Stein & Gary S. Stein. (2007) Nuclear microenvironments in biological control and cancer. Nature Reviews Cancer 7:6, pages 454-463.
Crossref
Crossref